Found 80 clinical trials
A Randomized, Double-blind, Placebo-controlled Dose-ranging Study of OPK-88004 Once-a-day Dosing for 16 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia. NCT03297398, SAR-202
prostatic hyperplasia (BPH).
- 513 views
- 02 Sep, 2021
- 1 location
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With Overactive Bladder (OAB) Symptoms While Taking the Alpha Blocker Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH). NCT02757768, 178-MA-1008.
lower urinary tract symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH). At Screening (Visit 1), subjects will enter into a 4-week open label tamsulosin hydrochloride 0.4 mg QD run-in period
- 205 views
- 02 Sep, 2021
- 1 location
The Effect of BRIZO on Lower Urinary Tract Symptoms (LUTS) Related to Benign Prostatic Hypertrophy (BPH)
A randomized, placebo controlled double-blind, 12-week treatment trial in men with moderate to severe symptoms of benign prostatic hyperplasia. The trail is about to examine the effect of Brizo®
- 0 views
- 22 Jul, 2022
- 1 location
WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia
benign prostatic hyperplasia with large prostates (80-180ml).
- 2 views
- 20 Jun, 2021
- 3 locations
ProVee Urethral Expander System IDE Study (ProVIDE) (ProVIDE)
to benign prostatic hyperplasia (BPH).
- 0 views
- 09 Aug, 2022
- 1 location
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Without Metastasis
Current agents administered in therapeutic regimens of prostate cancer employ different mechanisms to eliminate neoplastic cells by inducing substantial apoptosis and causing tumor regression. Treatment with neoadjuvant chemotherapy before radical prostatectomy may better control the tumor before it has the chance to convert into the disease of castration-resistant prostate cancer …
- 5 views
- 14 May, 2022
- 2 locations
Targeted Microwave Focal Therapy
Focal therapy (FT) for prostate cancer (PCa) is an interesting therapeutic option for localized disease with a favorable low- to intermediate-risk profile. The aim of this approach is to offer a personalized and less aggressive treatment as compared to radical treatments such as radical prostatectomy (RP) or primary radiation therapy, …
- 4 views
- 09 Mar, 2022
- 1 location
Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery (TEMPOUR)
Post-operative urinary retention (POUR) is a frequent complication reported as ranging from 10 to 55% in the literature. In a recent retrospective study from Laliberte et al in Quebec City, we observed that 19% of the patients operated using transanal endoscopic microsurgery (TEM) had a post-operative urinary retention (POUR). Factors …
- 290 views
- 31 Jan, 2022
- 1 location
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
benign prostatic hyperplasia.
- 0 views
- 15 Dec, 2021
- 1 location